RedHill Biopharma Ltd.（RDHL）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-08-07 | 6-K | — | SEC |
| 2026-08-06 | 6-K | — | SEC |
| 2026-07-28 | 6-K | — | SEC |
| 2026-07-01 | 6-K | — | SEC |
| 2026-06-29 | 6-K | — | SEC |
| 2026-06-25 | 6-K | — | SEC |
| 2026-06-22 | 6-K | — | SEC |
| 2026-06-22 | 6-K | — | SEC |
| 2026-06-22 | 6-K | — | SEC |
| 2026-06-18 | 6-K | — | SEC |
| 2026-06-09 | 6-K | — | SEC |
| 2026-06-08 | 6-K | — | SEC |
| 2026-06-02 | 6-K | — | SEC |
| 2026-05-27 | 6-K | — | SEC |
| 2026-04-30 | 6-K | — | SEC |
| 2026-04-27 | 6-K | — | SEC |
| 2026-04-22 | 6-K | — | SEC |
| 2026-04-14 | 6-K | — | SEC |
| 2026-03-05 | 6-K | — | SEC |
| 2026-02-25 | 6-K | — | SEC |
| 2026-01-27 | 6-K | — | SEC |
| 2026-01-22 | 6-K | — | SEC |
| 2026-01-05 | 6-K | — | SEC |
| 2025-12-31 | 6-K | — | SEC |
| 2025-12-23 | 6-K | — | SEC |
| 2025-12-15 | 6-K | — | SEC |
| 2025-12-01 | 6-K | — | SEC |
| 2025-11-26 | 6-K | — | SEC |
| 2025-11-04 | 6-K | — | SEC |
| 2025-10-22 | 6-K | — | SEC |
| 2025-10-21 | 6-K | — | SEC |
| 2025-10-20 | 6-K | — | SEC |
| 2025-10-06 | 6-K | — | SEC |
| 2025-09-29 | 6-K | — | SEC |
| 2025-09-05 | 6-K | — | SEC |
| 2025-08-20 | 6-K | — | SEC |
| 2025-08-18 | 6-K | — | SEC |
| 2025-08-14 | 6-K | — | SEC |
| 2025-07-21 | 6-K | — | SEC |
| 2025-07-01 | 6-K | — | SEC |
| 2025-06-25 | 6-K | — | SEC |
| 2025-05-27 | 6-K | — | SEC |
| 2025-05-19 | 6-K | — | SEC |
| 2025-05-13 | 6-K | — | SEC |
| 2025-05-05 | 6-K | — | SEC |
| 2025-05-02 | 6-K | — | SEC |
| 2025-04-28 | 6-K | — | SEC |
| 2025-04-17 | 6-K | — | SEC |
| 2025-04-16 | 6-K | — | SEC |
| 2025-04-10 | 6-K | — | SEC |
| 2025-04-08 | 6-K | — | SEC |
| 2025-04-01 | 6-K | — | SEC |
| 2025-03-26 | 6-K | — | SEC |
| 2025-03-18 | 6-K | — | SEC |
| 2025-03-12 | 6-K | — | SEC |
| 2025-02-27 | 6-K | — | SEC |
| 2025-02-25 | 6-K | — | SEC |
| 2025-02-04 | 6-K | — | SEC |
| 2025-02-03 | 6-K | — | SEC |
| 2025-01-21 | 6-K | — | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。